GI ProD-Tox

 Detoxification support
High-Potency, Non Dairy,  Probiotic Adjunct for Detoxification Protocols with acid-stable technology

 

(NOT SCD LEGAL) GI ProD-tox™ Detoxification Support probiotic supplement supplies large numbers of beneficial bacteria that support the body’s natural detoxification process and help maintain a healthy balance of friendly intestinal flora during detoxification protocols such as antibiotic therapy, antifungal /anti-microbial medications, or heavy metal chelating agents. A total probiotic count of 50+ billion CFUs of a combination of Lactobacillus rhamnosus, Lactobacillus casei, and Bifidobacterium bifidum is provided in each capsule.
 

Certified American Type Culture Collection (ATCC) probiotic strains of human origin are supplied in a base of inulin and encapsulated in two-piece Kosher-certified vegetarian capsules. GI ProHealths’ acid-stable delivery technology, a proprietary hypoallergenic polysaccharide complex, is included to protect microorganism potency during transit through the acidic gastric environment. GI ProD-tox™ Detoxification.
 

Support is a hypoallergenic product free of common allergens, including dairy products, casein, gluten, corn, soy, egg, sugar, yeast, and maltodextrin. No artificial additives, colorings, flavoring, preservatives, or salicylates are used. A small amount of L-leucine, a naturally-occurring amino acid, is used as an encapsulation aid.
 

OVERVIEW

Detoxification, defined as the reduction or removal of the toxic qualities of a substance, is an important part of the body’s natural defense process. Exposure to toxins such as heavy metals and other environmental pollutants, ingested chemicals including alcohol and drugs, infectious agents, and metabolic by-products occurs throughout an individual’s lifespan. Disease or even death can result when the burden of accumulated toxins outweighs the body’s ability to safely eliminate them. A variety of treatment regimens aimed at enhancing the body’s detoxification mechanisms are available to assist elimination or neutralization of toxic burdens. These include heavy metal chelating agents to reduce levels of mercury, lead, and other toxic elements; broad-spectrum antibiotics to eliminate bacterial pathogens; prescription anti-fungal or anti-parasitic agents; and nutritional compounds that help support intestinal and hepatic detoxification pathways. Some detoxification protocols, however, generate additional toxins or metabolic by-products that can further compromise health if they also are not efficiently cleared from the system. The normal, healthy balance of intestinal flora can be disturbed by some pharmaceutical agents or compromised by uncleared toxins, resulting in intestinal dysbiosis.
 

Increasing scientific evidence indicates that oral adminstration of probiotic organisms can support the body’s natural detoxification process in several ways. Probiotic supplements counterbalance the adverse effects on friendly flora from certain medications by replacing beneficial bacteria and thereby avoiding dysbiosis. They also assist detoxification processes by sequestering metals and other toxins, thereby inhibiting their uptake and facilitating safe elimination through the intestinal tract. Oral admistration of large populations of live, health-promoting lactic acid bacteria, referred to as probiotic bacteriotherapy, can augment detoxification protocols as follows:

 

Role of Probiotics in Detoxification Processes

Probiotics may beneficially modulate intestinal detoxification functions that naturally contribute to a protective effect on the colon. Gut flora, especially following the ingestion of resistant starch, induces the chemopreventive enzyme glutathione transferase in the colon of the rat. In humans, the ingestion of probiotics leads to the excretion of urine with low concentrations of components that are genotoxic in human colon cells and high concentrations of components that induce oxidized DNA bases. When ingested with prebiotics, probiotics facilitate the production of high concentrations of short-chain fatty acids. Butyrate, an important short-chain fatty acid that serves as fuel for colon cells, may inhibit the genotoxic activity of nitrosamides and hydrogen peroxide in human colon cells. Direct binding of heterocyclic aromatic amines (HAs) to the cell walls of certain bacterial strains contained in fermented foods has been observed to take place under physiologically relevant conditions. These observations suggest that intestinal bacteria may be useful for dietary detoxification and protection strategies to facilitate removal of selected mutagens.

 

Role of Probiotics in Anti-Microbial Protocols

Administration of pharmaceutical drugs for treatment of bacterial, viral, yeast, or parasitic infections not only results in death of pathogenic organisms but also liberates a number of toxins, cellular debris, and by-products into the intestinal tract following death of the cell. The body’s defenses are generally primed to respond to such an insult. However, use of these agents in individuals with compromised detoxification processes or gastrointestinal dysfunction may set the stage for adverse consequences that can manifest as a systemic (Herxheimer) reaction. The Herxheimer response (also described as a “die-off” reaction) can occur when live pathogens are killed and cellular toxins and by-products are released from lysed cells and transported into the circulation to be cleared from the body. Once absorbed into the bloodstream, these substances can cause adverse reactions that manifest as fatigue, skin hives, joint pain, or flu-like symptoms. Use of high potencies of probiotics can play a supportive role in clearing the released toxins and by-products from the intestinal tract before they have a chance to be absorbed, thereby lessening the likelihood of adverse responses.
 

Role of Probiotics in Metal Chelation Protocols

Use of heavy metal chelating agents such ethylenediaminetetraacetic acid (EDTA) and dimercaptosuccinic acid (DMPA) act to mobilize tissue stores of toxic metals and facilitate their removal from the body. This can result in production of toxic debris and other by-products of chelation that are passed into the intestinal lumen. Additionally, not all of the chelated metal will remain bound to the chelating agent during passage through the body. Once present in the intestinal tract, these compounds and liberated metals have the potential to adversely affect enterocytes and gut-associated lymphoid tissue (GALT) or be reabsorbed back into the bloodstream. These toxins and by-products may also adversely affect the live friendly intestinal flora, including Lactobacilli and Bifidobacterium strains, and/or serve as a food source for yeast and bacterial organisms. An exacerbation or onset of intestinal dysbiosis may result. Administration of live probiotics during chelation protocols can help maintain a healthy balance of friendly flora that help keep the population of undesirable organsims in check. Probiotics serve another useful role in the handling and clearance of metal compounds, as they are capable of sequestering mercury as it passes through the intestinal tract, thereby reducing its absorption. Probiotics also reduce highly toxic organic methylmercury into less toxic elemental mercury. Following internalization and detoxification of organic mercury within the probiotic organisms, elemental mercury escapes from the bacteria and is released back into the intestine. Here it may continue towards excretion, reabsorption, or reuptake by either pathogenic or probiotic bacteria. In the presence of chloride and strong acid, the elemental mercury may be converted into mercuric chloride that can then be taken up by either pathogenic or probiotic bacteria. Interestingly, it is known that both pathogenic and beneficial enteric bacteria, as well as yeasts, are all capable of producing methylmercury from mercuric chloride. However, pathogenic organisms such as E. coli make this conversion at a much faster rate, yielding 2 to 7.5 times more methylmercury in the same perod of time. Yeast were shown to make the conversion more than 4 times faster than probiotic organisms. Consequently, when beneficial bacteria predominate, their ability to sequester and move mercury towards excretion coupled with a much slower reconversion rate has the net effect of eliminating mercury in a less toxic form and reducing the opportunity for mercury to adversely affect GI tissues or be reabsorbed.
 

PROBIOTIC STRAINS

GI ProD-tox™ Detoxification Support supplies high concentrations of three selected probiotic strains noted for protective activities as follows:
 

Lactobacilllus rhamnosus

As a primary resident of the small intestine, Lactobacilllus rhamnosus adheres to and colonizes the mucosal membrane where it exerts important health-promoting functions. It enhances cellular immunity by increasing immunoglobulin IgA and stimulating phagocytosis. It also reduces intestinal inflammation and mucosal barrier permeability in infants with allergic dermatitis. This strain functions by competitive exclusion of pathogenic organisms including E. coli, Listeria, Clostridia, Shigella and Salmonella, etc. L. rhamnosus can also assist the immune system in resisting pathogenic organisms such as bacteria and yeast that promote intestinal inflammation and damage membranes.
 

Lactobacillus casei

L. casei is a common lactic acid bacteria found in the mouth and membrane of the small intestine where it shares many of the same immune-modulating effects exerted by other lactobacilli family members. It helps intestinal cells respond appropriately when the immune system is challenged by enhancing the number of IgA-producing cells in the mucosal membrane. T-lymphocytes, which have an important role in the mucosal immune response, are also increased by higher populations of L. casei. The cell wall of the L. casei strain contains teichoic acid which participates in adherence of L. casei to epithelial tissue where it inhibits attachment of pathogenic organisms. A protective effect against DNA damage in cells in the GI tract has been observed when high concentrations of L. casei are administered prior to carcinogen exposure in rats. Bifidobacterium bifidum B. bifidum (also recognized as B. lactis) is primarily found in the digestive system of adults and children, but is especially important to and prevalent in high numbers in breastfed infants. B. bifidum is a common resident in the mucus membranes lining the distal part of the small intestine, the large intestine, and the vaginal tract, where it attaches to the luminal walls, crowding out yeast (Candida albicans) and pathogens (Clostridium, Salmonella, etc.) by competing for nutrients. B. bifidum also produces acetic and lactic acid, which lowers the pH (increases the acidity) of the intestine, thus inhibiting growth of undesirable bacteria. A role in detoxification has been demonstrated with use of this bifidobacterium strain. B. bifidum administered to 20 patients with liver disease produced a significant decrease in blood ammonia, free serum phenol, and free amino nitrogen.
 

INULIN OLIGOSACCHARIDE BASE

Inulin is a natural, non-digestible oligosaccharide derived from the chicory root vegetable. Recognized for its ability to function as a pre-biotic, inulin is used as a fuel source to stimulate or increase the growth of beneficial bacteria (Bifidobacteria) which have a role in reducing the growth of pathogens in the intestinal tract. This naturally-derived base ingredient is generally well-tolerated by the highly sensitive person. It is used in place of corn- or wheat-derived maltodextrin, commonly use as a base ingredient in the majority of probiotic supplements.
 

ACID-STABLE DELIVERY SYSTEM

Probiotic viability of GI ProD-tox™ Detoxification Support is protected by an acid stable technology.

This technology  is highly purified polysaccharide material of marine origin that forms a gel-like matrix that surrounds

and protects the probiotic bacteria from destruction by gastric acid. This allows the friendly flora to survive exposure to stomach acids and be delivered alive into the small intestines where they are released intact to exert their health promoting function.
 

INDICATIONS

GI ProD-tox™ Detoxification Support is recommended whenever support for intestinal detoxification mechanisms is indicated. It may be especially useful in conjunction with agents that may adversely affect the population of beneficial intestinal flora, including during and following use of broad-spectrum antibiotics, anti-microbial or anti-parasitic medications, anti-fungals/anti-candida drugs, or heavy metal chelating compounds. GI ProD-tox™ Detoxification Support may also be used whenever an intensive approach to replacement with large quantities of probiotic Lactobacillus and Bifidobacterium is desired.

 

GI ProD-tox™ Detoxification Support provides two colonizing Lactobacillus and one endogenous Bifidobacterium probiotic species that can support the body’s natural detoxification process by metabolizing or reducing the uptake of toxins in the gut thereby facilitating the elimination of toxins and by-products from the intestinal tract. Formulated with 50+ billion CFUs per capsule, GI ProD-tox™ Detoxification Support uses proprietary technology to ensure maximum delivery of live microorganisms throughout the intestinal tract. Once a healthy balance of intestinal flora is achieved, use of GI PROx12™ is recommended for daily maintenance.

 

 

GI ProD-tox™ Supplement Facts and FAQ’s
 

1. Who should take GI ProD-tox™ ?

GI ProD-tox™ Detoxification Support is recommended whenever support for intestinal detoxification

mechanisms is indicated. GI ProD-tox™ Detoxification Support may also be used whenever an intensive approach

to replacement with large quantities of probiotic Lactobacillus and Bifidobacterium is desired.

2. Is there any drug interactions when using GI ProD-tox™ ?

No there are no known drug interactions

3. Is there any Contraindictions with GI ProD-tox™ ?

Individuals sensitive to chicory root (inulin source) may wish to avoid use of this product.

4. Can GI ProD-tox™ be taken with food?

Yes it can be taken with food.

5. Is GI ProD-tox™ a “SCD Legal” product?

No it is NOT “SCD Legal”

6. How many CFUs per capsule is in GI ProD-tox™ ?

50 billion CFUs  per capsule

7. Is GI ProD-tox™ a probiotic?

Yes it is considered a probiotic

8. Does GI ProD-tox™ require refrigeration?

Yes it does require refrigeration.

9. How is it shipped?

As in all of our probiotics it is shipped in ice packs in an insulated box to minimize the amount of time exposed to warmer temperatures during transit.

10. Does GI ProD-tox™ contain inulin?

Yes it does contain inulin derived from chicory root.

 

 

Supplement Facts Serving Size 1 Capsule Amount Per Capsule % Daily Value Probiotic Blend 208 mg * Lactobacillus rhamnosus 20+ billion CFUs * Bifidobacterium bifidum 15+ billion CFUs * Lactobacillus casei 15+ billion CFUs * * Daily value not established

Other Ingredients: Inulin base derived from chicory root, Vcaps™ vegetarian capsule, proprietary polysaccharide complex, water, and L-leucine.

Have any questions not answered here?

Feel free to e mail us at info@giprohealth.com.

Or call 774-328-2472

Call 1-877-447-7648 to leave a message or place a phone order

Note: when making phone purchases please be sure to speak slowly and include all credit card information and full address also please leave an e mail address if possible for notifications of delivery.

GI ProHealth does NOT sell or share any customer information for any reason what so ever.

 

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.